Multiple sclerosis prevalence in the United States commercially insured population

P Dilokthornsakul, RJ Valuck, KV Nair, JR Corboy… - Neurology, 2016 - AAN Enterprises
Objective: To estimate the US commercially insured multiple sclerosis (MS) annual
prevalence from 2008 to 2012. Methods: The study was a retrospective analysis using …

Multiple sclerosis prevalence in the United States commercially insured population.

P Dilokthornsakul, RJ Valuck, KV Nair, JR Corboy… - Neurology, 2016 - europepmc.org
Objective To estimate the US commercially insured multiple sclerosis (MS) annual
prevalence from 2008 to 2012. Methods The study was a retrospective analysis using …

Multiple sclerosis prevalence in the United States commercially insured population

P Dilokthornsakul, RJ Valuck, KV Nair… - …, 2016 - pubmed.ncbi.nlm.nih.gov
Objective To estimate the US commercially insured multiple sclerosis (MS) annual
prevalence from 2008 to 2012. Methods The study was a retrospective analysis using …

[HTML][HTML] Multiple sclerosis prevalence in the United States commercially insured population

P Dilokthornsakul, RJ Valuck, KV Nair, JR Corboy… - Neurology, 2016 - ncbi.nlm.nih.gov
Objective: To estimate the US commercially insured multiple sclerosis (MS) annual
prevalence from 2008 to 2012. Methods: The study was a retrospective analysis using …

Multiple sclerosis prevalence in the United States commercially insured population.

P Dilokthornsakul, RJ Valuck, KV Nair, JR Corboy… - 2016 - cabidigitallibrary.org
Objective: To estimate the US commercially insured multiple sclerosis (MS) annual
prevalence from 2008 to 2012. Methods: The study was a retrospective analysis using …

Multiple sclerosis prevalence in the United States commercially insured population.

P Dilokthornsakul, RJ Valuck, KV Nair, JR Corboy… - Neurology, 2016 - europepmc.org
Objective To estimate the US commercially insured multiple sclerosis (MS) annual
prevalence from 2008 to 2012. Methods The study was a retrospective analysis using …